FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
27,310,534
Share change
+1,997,108
Total reported value
$166,610,880
Put/Call ratio
0%
Price per share
$6.10
Number of holders
94
Value change
+$13,931,528
Number of buys
49
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q2 2020

As of 30 Jun 2020, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,310,534 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Assenagon Asset Management S.A., ACADIAN ASSET MANAGEMENT LLC, and Candriam Luxembourg S.C.A.. This page lists 94 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.